Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Page Path

HOME
ARTICLE CATEGORY
Review

Review

Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues

Dong Joon Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(2):115-122. Published online May 2, 2017

DOI: https://doi.org/10.3350/cmh.2017.0018

View: 8923 Download: 228 Web of Science: 12 Crossref: 14

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol. 2017;23(2):109-114. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0004

View: 12224 Download: 362 Web of Science: 46 Crossref: 41

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol. 2017;23(2):103-108. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0103

View: 11924 Download: 472 Web of Science: 30 Crossref: 30

The use of immunosuppression in autoimmune hepatitis: A current literature review

Angela Cropley, Martin Weltman

Clin Mol Hepatol. 2017;23(1):22-26. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0089

View: 28967 Download: 418 Web of Science: 15 Crossref: 18

Anticoagulation in cirrhosis: a new paradigm?

Filippo Leonardi, Nicola De Maria, Erica Villa

Clin Mol Hepatol. 2017;23(1):13-21. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0110

View: 14707 Download: 810 Web of Science: 46 Crossref: 50

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2017;23(1):1-12. Published online March 9, 2017

DOI: https://doi.org/10.3350/cmh.2016.0109

View: 17647 Download: 601 Web of Science: 145 Crossref: 144

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol. 2016;22(4):432-438. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0107

View: 11010 Download: 364 Web of Science: 29 Crossref: 27

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 12806 Download: 545 Web of Science: 48 Crossref: 47

Acute kidney injury in liver cirrhosis: new definition and application

Florence Wong

Clin Mol Hepatol. 2016;22(4):415-422. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0056

View: 13934 Download: 760 Web of Science: 52 Crossref: 55

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen

Clin Mol Hepatol. 2016;22(3):327-335. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0049

View: 15374 Download: 533 Web of Science: 51 Crossref: 51

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 13186 Download: 392 Web of Science: 67 Crossref: 68

Liver transplantation for advanced hepatocellular carcinoma

Hae Won Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2016;22(3):309-318. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0042

View: 12166 Download: 268 Web of Science: 22 Crossref: 21

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 16644 Download: 649 Web of Science: 81 Crossref: 83

Current status of laparoscopic liver resection for hepatocellular carcinoma

Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Mohan Periyasamy

Clin Mol Hepatol. 2016;22(2):212-218. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2016.0026

View: 12888 Download: 287 Web of Science: 54 Crossref: 51

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol. 2016;22(2):199-211. Published online May 18, 2016

DOI: https://doi.org/10.3350/cmh.2016.0101

View: 18244 Download: 611 Web of Science: 40 Crossref: 37

KASL clinical practice guidelines: management of hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2016;22(1):76-139. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.76

View: 25986 Download: 207 Web of Science: 64 Crossref: 54

KASL clinical practice guidelines: management of chronic hepatitis B

Clin Mol Hepatol. 2016;22(1):18-75. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.18

View: 24452 Download: 261 Web of Science: 151 Crossref: 134

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 19717 Download: 544 Web of Science: 219 Crossref: 203

Acute-on-chronic liver failure: a new syndrome in cirrhosis

Richard Moreau

Clin Mol Hepatol. 2016;22(1):1-6. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.1

View: 14363 Download: 341 Web of Science: 28 Crossref: 29

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(4):344-348. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.344

View: 8104 Download: 194 Web of Science: 27 Crossref: 25

Imaging findings of mimickers of hepatocellular carcinoma

Tae Kyoung Kim, Eunchae Lee, Hyun-Jung Jang

Clin Mol Hepatol. 2015;21(4):326-343. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.326

View: 41369 Download: 976 Web of Science: 22 Crossref: 24

Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase

Yasuko Iwakiri

Clin Mol Hepatol. 2015;21(4):319-325. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.319

View: 12156 Download: 227 Web of Science: 69 Crossref: 74

The mutational landscape of hepatocellular carcinoma

Ju-Seog Lee

Clin Mol Hepatol. 2015;21(3):220-229. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.220

View: 13935 Download: 381 Web of Science: 89 Crossref: 79

Managing alcoholic liver disease

Vijay H. Shah

Clin Mol Hepatol. 2015;21(3):212-219. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.212

View: 8937 Download: 253 Web of Science: 14 Crossref: 14

Personalized management of cirrhosis by non-invasive tests of liver fibrosis

Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong

Clin Mol Hepatol. 2015;21(3):200-211. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.200

View: 9470 Download: 125 Web of Science: 24 Crossref: 26

From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor

Jisu Li, Shuping Tong

Clin Mol Hepatol. 2015;21(3):193-199. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.193

View: 8623 Download: 199 Web of Science: 9 Crossref: 10

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(2):115-121. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.115

View: 10176 Download: 143 Web of Science: 40 Crossref: 31

Hepatitis C virus-induced hepatocellular carcinoma

Nicolas Goossens, Yujin Hoshida

Clin Mol Hepatol. 2015;21(2):105-114. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.105

View: 18431 Download: 336 Web of Science: 113 Crossref: 108

The cost of liver disease in Korea: methodology, data, and evidence

Wankyo Chung

Clin Mol Hepatol. 2015;21(1):14-21. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.14

View: 7760 Download: 106 Web of Science: 17 Crossref: 17

Clinical implications of advances in liver regeneration

Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi

Clin Mol Hepatol. 2015;21(1):7-13. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.7

View: 11063 Download: 217 Web of Science: 49 Crossref: 43

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

04 Days

*Last 12 months

Viewed By 5150	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5017	MAFLD: How is it different from NAFLD?
Viewed By 4924	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3643	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3590	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?